ouabain has been researched along with tamoxifen in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Graves, SW; Hollenberg, NK; Soszynski, PA; Tao, QF | 1 |
| Cunha, VM; Noël, F; Reis, JM | 1 |
| Chen, ZY; Huang, Y; Ko, WH; Laher, I; Leung, FP; Leung, HS; Yao, X; Yung, LM | 1 |
| Bindslev, N; Hansen, MB; Kaltoft, N; Osbak, PS; Poulsen, SS; Tilotta, MC; Witte, AB | 1 |
| Cararo, JH; Carvalho, AF; Dal-Pont, GC; Gava, FF; Mina, FG; Peterle, BR; Quevedo, J; Resende, WR; Valvassori, SS; Varela, RB | 1 |
| Bianchini, G; Dal-Pont, GC; Gava, FF; Peterle, BR; Quevedo, J; Resende, WR; Trajano, KS; Valvassori, SS; Varela, RB | 1 |
| Acconcia, F | 1 |
12 other study(ies) available for ouabain and tamoxifen
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A sensitive [Na,K]ATPase assay specific for inhibitors acting through the digitalis-binding site.
Topics: Animals; Antineoplastic Agents; Binding, Competitive; Bufanolides; Cattle; Digitalis; Digoxin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kidney; Lysophosphatidylcholines; Oleic Acid; Oleic Acids; Ouabain; Plants, Medicinal; Plants, Toxic; Regression Analysis; Silver Nitrate; Sodium-Potassium-Exchanging ATPase; Steroids; Tamoxifen; Vanadates | 1995 |
Evidence for the presence of two (Ca(2+)-Mg2+) ATPases with different sensitivities to thapsigargin and cyclopiazonic acid in the human flatworm Schistosoma mansoni.
Topics: Animals; Binding Sites; Ca(2+) Mg(2+)-ATPase; Calcium-Transporting ATPases; Calmodulin; Enzyme Inhibitors; Indoles; Male; Mice; Microsomes; Ouabain; Schistosoma mansoni; Subcellular Fractions; Tamoxifen; Thapsigargin | 1996 |
Tamoxifen dilates porcine coronary arteries: roles for nitric oxide and ouabain-sensitive mechanisms.
Topics: Animals; Calcium; Coronary Vessels; Cycloheximide; Dactinomycin; Estradiol; Free Radical Scavengers; Nitric Oxide; Nitric Oxide Synthase Type III; Nitroprusside; Ouabain; Phosphorylation; Potassium Channel Blockers; Swine; Tamoxifen | 2006 |
Prostaglandin E2-induced colonic secretion in patients with and without colorectal neoplasia.
Topics: Alprostadil; Biopsy; Bumetanide; Colforsin; Colon; Colorectal Neoplasms; Dinoprostone; Female; Humans; Ion Transport; Lubiprostone; Male; Middle Aged; Ouabain; Prostaglandin-Endoperoxide Synthases; Receptors, Prostaglandin E; Reference Values; Signal Transduction; Tamoxifen; Theophylline | 2010 |
Lithium and Tamoxifen Modulate Behavior and Protein Kinase C Activity in the Animal Model of Mania Induced by Ouabain.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Bipolar Disorder; Brain; Disease Models, Animal; Drug Administration Routes; Enzyme Inhibitors; Lithium; Locomotion; Male; Ouabain; Protein Kinase C; Rats; Rats, Wistar; Tamoxifen | 2017 |
Tamoxifen has an anti-manic effect but not protect the brain against oxidative stress in an animal model of mania induced by ouabain.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Brain; Disease Models, Animal; Male; Ouabain; Oxidative Stress; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Tamoxifen | 2019 |
Evaluation of the Sensitivity of Breast Cancer Cell Lines to Cardiac Glycosides Unveils ATP1B3 as a Possible Biomarker for the Personalized Treatment of ERα Expressing Breast Cancers.
Topics: Adenosine Triphosphatases; Anastrozole; Aromatase Inhibitors; Biomarkers; Breast Neoplasms; Cardiac Glycosides; Cell Line, Tumor; Epidermal Growth Factor; ErbB Receptors; Erlotinib Hydrochloride; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Letrozole; MCF-7 Cells; Ouabain; Precision Medicine; Sodium-Potassium-Exchanging ATPase; Tamoxifen | 2022 |